Mario Crovetto
Chief Executive Officer bei IKONISYS S.A.
Vermögen: 1 043 $ am 31.03.2024
Profil
Mario P.
Crovetto is currently the Chief Executive Officer & Director at Ikonisys SA. He is also a Member-Supervisory Board at Curetis GmbH.
Previously, he served as an Independent Director at OpGen, Inc. from 2020 to 2024.
Prior to that, he was the Chief Financial Officer at Eurand NV from 1999 to 2011 and the CFO & Vice President-Corporate Development at Recordati SpA from 1990 to 1999.
He also served as an Independent Member-Supervisory Board at Curetis NV from 2015 to 2020.
Mr. Crovetto holds a graduate degree from Harvard University and an undergraduate degree from Università Cattolica del Sacro Cuore Campus di Milano.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPGEN, INC.
0,01% | 30.06.2023 | 1 500 ( 0,01% ) | 1 043 $ | 31.03.2024 |
Aktive Positionen von Mario Crovetto
| Unternehmen | Position | Beginn |
|---|---|---|
| IKONISYS S.A. | Chief Executive Officer | 01.07.2021 |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Director/Board Member | - |
Ehemalige bekannte Positionen von Mario Crovetto
| Unternehmen | Position | Ende |
|---|---|---|
| OPGEN, INC. | Director/Board Member | 25.03.2024 |
| CURETIS N.V. | Director/Board Member | 01.04.2020 |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Director of Finance/CFO | 01.01.2011 |
| RECORDATI | Director of Finance/CFO | 01.01.1999 |
Ausbildung von Mario Crovetto
| Harvard University | Graduate Degree |
| Università Cattolica del Sacro Cuore Campus di Milano | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| OPGEN, INC. | Commercial Services |
| RECORDATI | Health Technology |
| IKONISYS S.A. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Eurand NV
Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Technology |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Services |
